The role of mesenchymal stem cells in promoting the transformation of androgen-dependent human prostate cancer cells into androgen-independent manner

被引:22
作者
Cheng, Jiwen [1 ]
Yang, Keqin [2 ]
Zhang, Qingyun [1 ]
Yu, Yang [1 ]
Meng, Qinggui [1 ]
Mo, Ning [4 ]
Zhou, Yang [1 ]
Yi, Xianlin [1 ]
Ma, Chengzhong [1 ]
Lei, Aming [3 ]
Liu, Yan [3 ]
机构
[1] Guangxi Med Univ, Dept Urol, Affiliated Tumor Hosp, Nanning, Peoples R China
[2] Guigang City Peoples Hosp, Dept Orthoped, Guigang, Peoples R China
[3] Guangxi Med Univ, Dept Chemotherapy 5, Affiliated Tumor Hosp, Nanning, Peoples R China
[4] Guangxi Univ Chinese Med, Dept Oncol, Ruikang Hosp, Nanning, Peoples R China
基金
中国国家自然科学基金;
关键词
TUMOR-GROWTH;
D O I
10.1038/srep16993
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mesenchymal stem cells (MSCs) play an important role in the development of human prostate cancer (PCa). However, the role of MSCs in the transformation of androgen-dependent human PCa cells into androgen-independent manner has been poorly understood. In this study, we investigated the underlying mechanism of MSCs in promoting PCa cells from androgen-dependent into androgen-independent manner. Firstly, we demonstrated that MSCs could affect the transformation of androgen-dependent human PCa cells into androgen-independent manner in vivo and in vitro. Then we found a substantial expression of TGF-beta in MSCs. TGF-beta blockade could significantly inhibit the promotive function of MSCs in PCa cells. Besides that, we also demonstrated androgen might inhibit the expression of TGF-beta in MSCs. Furthermore, we found that either overexpression of SSEA-4 or the number of SSEA-4 positive MSCs in PCa tissues was associated with a shorter cancer-free survival interval (CFSI) and a worse overall survival (OS). Our results suggest that androgen blockade treatment in clinical PCa therapy may elicit the expression of TGF-beta in MSCs, which will result in the transformation of androgen-dependent human PCa cells into androgen-independent manner.
引用
收藏
页数:10
相关论文
共 33 条
[1]   Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment [J].
Anjos-Afonso, Fernando ;
Bonnet, Dominique .
BLOOD, 2007, 109 (03) :1298-1306
[2]   Mesenchymal stem cells: clinical applications and biological characterization [J].
Barry, FP ;
Murphy, JM .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (04) :568-584
[3]   Marrow stromal stem cells [J].
Bianco, P ;
Robey, PG .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (12) :1663-1668
[4]   Mesenchymal stem cells: Revisiting history, concepts, and assays [J].
Bianco, Paolo ;
Robey, Pamela Gehron ;
Simmons, Paul J. .
CELL STEM CELL, 2008, 2 (04) :313-319
[5]   Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment [J].
Brennen, W. Nathaniel ;
Denmeade, Samuel R. ;
Isaacs, John T. .
ENDOCRINE-RELATED CANCER, 2013, 20 (05) :R269-R290
[6]   Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer [J].
Culig, Zoran .
JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (02) :270-274
[7]   Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease [J].
D'Agostino, Bruno ;
Sullo, Nikol ;
Siniscalco, Dario ;
De Angelis, Antonella ;
Rossi, Francesco .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (05) :681-687
[8]   Mesenchymal stem cells: Biology and potential clinical uses [J].
Deans, RJ ;
Moseley, AB .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (08) :875-884
[9]   Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli [J].
Di Nicola, M ;
Carlo-Stella, C ;
Magni, M ;
Milanesi, M ;
Longoni, PD ;
Matteucci, P ;
Grisanti, S ;
Gianni, AM .
BLOOD, 2002, 99 (10) :3838-3843
[10]   Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen-induced arthritis [J].
Djouad, F ;
Fritz, V ;
Apparailly, F ;
Louis-Plence, P ;
Bony, C ;
Sany, J ;
Jorgensen, C ;
Noël, D .
ARTHRITIS AND RHEUMATISM, 2005, 52 (05) :1595-1603